Daniel Janney - Net Worth and Insider Trading

Daniel Janney Net Worth

The estimated net worth of Daniel Janney is at least $34 Million dollars as of 2024-03-28. Daniel Janney is the Director of Krystal Biotech Inc and owns about 107,362 shares of Krystal Biotech Inc (KRYS) stock worth over $19 Million. Daniel Janney is the Director, 10% Owner of Allakos Inc and owns about 9,050,493 shares of Allakos Inc (ALLK) stock worth over $12 Million. Daniel Janney is also the Director of Esperion Therapeutics Inc and owns about 1,366,987 shares of Esperion Therapeutics Inc (ESPR) stock worth over $4 Million. Besides these, Daniel Janney also holds Viveve Medical Inc (VIVE) . Details can be seen in Daniel Janney's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Janney has not made any transactions after 2023-06-09 and currently still holds the listed stock(s).

Transaction Summary of Daniel Janney

To

Daniel Janney Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Janney owns 21 companies in total, including Krystal Biotech Inc () , Esperion Therapeutics Inc () , and Allakos Inc () among others .

Click here to see the complete history of Daniel Janney’s form 4 insider trades.

Insider Ownership Summary of Daniel Janney

Ticker Comapny Transaction Date Type of Owner
Krystal Biotech Inc 2023-06-09 director
Esperion Therapeutics Inc 2017-03-21 director
Allakos Inc 2022-09-21 director
Sutro Biopharma Inc 2018-09-26 director & 10 percent owner
Viveve Medical Inc 2017-03-17 director & 10 percent owner
Evofem Biosciences Inc 2014-11-19 director & 10 percent owner
ZS Pharma Inc 2015-06-05 10 percent owner
aTyr Pharma Inc 2015-05-06 10 percent owner
KalVista Pharmaceuticals Inc 2015-04-08 10 percent owner
Trevena Inc 2014-01-30 10 percent owner
Applied Genetic Technologies Corp 2014-03-26 10 percent owner
Immune Design Corp 2014-07-29 10 percent owner
Aerie Pharmaceuticals Inc 2013-10-25 10 percent owner
Ellie Mae Inc 2011-04-20 10 percent owner
Talphera Inc 2011-02-10 10 percent owner
Raptor Pharmaceutical Corp 2009-09-03 other: No longer 10% owner
NeurogesX Inc 2007-05-07 10 percent owner
Dynavax Technologies Corp 2004-02-11 director
Cutera Inc 2004-03-31 10 percent owner
Avadel Pharmaceuticals PLC 2003-08-27 10 percent owner
Tyra Biosciences Inc 2021-09-14 10 percent owner

Daniel Janney Latest Holdings Summary

Daniel Janney currently owns a total of 4 stocks. Among these stocks, Daniel Janney owns 107,362 shares of Krystal Biotech Inc (KRYS) as of June 9, 2023, with a value of $19 Million and a weighting of 55.63%. Daniel Janney owns 9,050,493 shares of Allakos Inc (ALLK) as of September 21, 2022, with a value of $12 Million and a weighting of 33.91%. Daniel Janney also owns 1,366,987 shares of Esperion Therapeutics Inc (ESPR) as of March 21, 2017, with a value of $4 Million and a weighting of 10.46%. The other 1 stocks Viveve Medical Inc (VIVE) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Daniel Janney

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KRYS Krystal Biotech Inc 2023-06-09 107,362 177.04 19,007,368
ALLK Allakos Inc 2022-09-21 9,050,493 1.28 11,584,631
ESPR Esperion Therapeutics Inc 2017-03-21 1,366,987 2.62 3,574,671
VIVE Viveve Medical Inc 2017-03-17 1,385 0.00 0

Holding Weightings of Daniel Janney


Daniel Janney Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Janney has made a total of 6 transactions in Krystal Biotech Inc (KRYS) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Krystal Biotech Inc is the sale of 50,000 shares on June 9, 2023, which brought Daniel Janney around $6 Million.

According to the SEC Form 4 filings, Daniel Janney has made a total of 5 transactions in Allakos Inc (ALLK) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Allakos Inc is the acquisition of 475,000 shares on September 21, 2022, which cost Daniel Janney around $2 Million.

According to the SEC Form 4 filings, Daniel Janney has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the sale of 350,000 shares on March 21, 2017, which brought Daniel Janney around $16 Million.

More details on Daniel Janney's insider transactions can be found in the Insider Trading History of Daniel Janney table.

Insider Trading History of Daniel Janney

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Janney Trading Performance

GuruFocus tracks the stock performance after each of Daniel Janney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Janney is 40.48%. GuruFocus also compares Daniel Janney's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Janney within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel Janney's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel Janney

Average Relative Return

-2.85%

Average relative return per transaction

Outperforming Transactions

33%

2 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 18.35 40.48 61.69 -2.85 46.2 4.46
Relative Return to S&P 500(%) 15.93 37.29 56.2 -16.23 37.37 -4.99

Daniel Janney Ownership Network

Ownership Network List of Daniel Janney

No Data

Ownership Network Relation of Daniel Janney


Daniel Janney Owned Company Details

What does Krystal Biotech Inc do?

Who are the key executives at Krystal Biotech Inc?

Daniel Janney is the director of Krystal Biotech Inc. Other key executives at Krystal Biotech Inc include director & 10 percent owner & President and CEO Krish S Krishnan , director & 10 percent owner & Chief Operating Officer Suma Krishnan , and Chief Accounting Officer Kathryn Romano .

Krystal Biotech Inc () Insider Trades Summary

Over the past 18 months, Daniel Janney made 4 insider transaction in Krystal Biotech Inc () with a net sale of 125,000. Other recent insider transactions involving Krystal Biotech Inc () include a net sale of 350,000 shares made by Krish S Krishnan , a net sale of 350,000 shares made by Suma Krishnan , and a net sale of 76,515 shares made by Kathryn Romano .

In summary, during the past 3 months, insiders sold 123,087 shares of Krystal Biotech Inc () in total and bought 0 shares, with a net sale of 123,087 shares. During the past 18 months, 954,015 shares of Krystal Biotech Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 954,015 shares.

Krystal Biotech Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Krystal Biotech Inc Insider Transactions

No Available Data

Daniel Janney Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Janney. You might contact Daniel Janney via mailing address: Po Box 7414, Jackson Wy 83002.

Discussions on Daniel Janney

No discussions yet.